Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 11.29% is 37% above its 5-year average of 8.26%, near the low end of its 5-year range (0.00%–127.83%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.50% below its 12-month average of 12.47%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.29%.
DEBT TO ASSETS RATIO
11.29%
DEBT TO ASSETS RATIO AVG TTM
12.47%
DEBT TO ASSETS RATIO AVG 3Y
12.88%
DEBT TO ASSETS RATIO AVG 5Y
8.26%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.50%
CURRENT VS 3Y AVG
-12.39%
CURRENT VS 5Y AVG
+36.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+12440.45%
vs the sector median at left
Alpha Tau Medical Ltd
Market Cap
$1.31B
Debt to Assets Ratio
11.29%
TTM Avg
12.47%
3Y Avg
12.88%
5Y Avg
8.26%
Market Cap
$1.33B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.37B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.24B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.39B
Debt to Assets Ratio
0.48%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.22B
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Tau Medical Ltd (DRTS) | $1.31B | 11.29% | 12.47% | 12.88% | 8.26% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.33B | 0.00% | N/A | N/A | N/A |
| Omeros Corporation (OMER)vs › | $1.34B | 0.29% | N/A | N/A | N/A |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | 0.03% | N/A | N/A | N/A |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | 0.01% | N/A | N/A | N/A |
| Omada Health (OMDA)vs › | $1.23B | 0.00% | N/A | N/A | N/A |
| Cronos Group Inc. (CRON)vs › | $1.23B | 0.00% | N/A | N/A | N/A |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 0.48% | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 0.16% | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.40B | N/A | N/A | N/A | N/A |
Debt/Assets
11.3%
Debt/Equity
0.34
Current Ratio
11.09
Interest Coverage
-100.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 11.29% |
| 2026-03-31 | 13.18% |
| 2025-12-31 | 12.99% |
| 2025-09-30 | 12.90% |
| 2025-06-30 | 12.00% |
| 2025-03-31 | 15.19% |
| 2024-12-31 | 14.54% |
| 2024-09-30 | 13.85% |
| 2024-06-30 | 13.07% |
| 2024-03-31 | 12.63% |
| 2023-12-31 | 12.36% |
| 2023-09-30 | 5.67% |
| 2023-06-30 | 5.65% |
| 2023-03-31 | 5.55% |
| 2022-12-31 | 4.32% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 127.83% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 101.84% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
